Quadrature Capital Ltd

Position in LLY — ELI LILLY & Co

CIK 1651424 LONDON, X0

Position in LLY

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$90,873,622

+$29,251,792 QoQ

Shares Held

75,764

+13.1% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.91%

of 13F equity value

Holder Rank

#406

of 4,605 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Quadrature Capital Ltd holds $269,077,008 across 11 Drug Manufacturers - General names. LLY ranks #1 (33.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	75,764	$90,873,622
2	ABBV	AbbVie Inc.	212,852	$53,562,077
3	NVS	Novartis AG	240,579	$37,703,540
4	AZN	Astrazeneca PLC	157,534	$29,871,597
5	NVO	Novo Nordisk A S	522,349	$25,041,411
6	PFE	Pfizer Inc	978,887	$23,571,598
7	SNY	Sanofi	60,025	$2,560,666
8	MRK	Merck & Co., Inc.	15,260	$1,960,910

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$90,873,622	75,764	+13.1%	Shares	Other	2026-08-07
2026-03-31	$61,621,830	66,997	-69.0%	Shares	Other	2026-05-15
2025-12-31	$231,984,745	215,864	+86.3%	Shares	Other	2026-02-17
2025-09-30	$88,404,232	115,864	+122.7%	Shares	Other	2025-11-13
2024-12-31	$40,173,336	52,038	-44.4%	Shares	Other	2025-02-13
2024-09-30	$82,951,448	93,631	+75.8%	Shares	Defined	2024-11-14
2023-09-30	$28,607,543	53,260	-52.8%	Shares	Sole	2023-11-14
2023-06-30	$52,935,179	112,873	+226.3%	Shares	Sole	2023-08-14
2023-03-31	$11,880,271	34,594	+2.0%	Shares	Sole	2023-05-15
2021-12-31	$9,364,686	33,903	+19.5%	Shares	Sole	2022-02-14
2021-09-30	$6,555,119	28,371	+307.5%	Shares	Sole	2021-11-15
2020-12-31	$1,175,632	6,963	-94.5%	Shares	Sole	2021-02-16
2020-09-30	$18,683,824	126,225	+284.8%	Shares	Sole	2020-11-13
2020-06-30	$5,385,760	32,804	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.